Meanwhile, the FE BMP-2 and BMP-6 values, which increased with the progression of CKD, but did not exceed the 1% threshold in CKD stages 1–2, could act as surrogate markers for the enhanced tubular activity. This evidence concerns the gene BMP6 and chronic kidney disease.